Sai Life Sciences Quarterly Results for Trading Insights

SAILIFE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹84 Cr
QSept 2025
Quarterly Results

Sai Life Sciences Quarterly Results Key Highlights

  • Revenue of ₹553 Cr in Sept 2025 (-6.1% vs Mar 2025, +36.2% vs Sept 2024)
  • Net Profit of ₹84 Cr in Sept 2025 (-4.5% vs Mar 2025, +100.0% vs Sept 2024)
  • EBITDA of ₹161 Cr in Sept 2025 (-3.6% vs Mar 2025)
  • Operating Margin of 27.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹4.01 in Sept 2025 (-5.4% vs Mar 2025)

Sai Life Sciences Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 553 589 506 565 406 -6.1% 36.2%
Net Profit (₹ Cr) 84 88 61 100 42 - -
EBITDA (₹ Cr) 161 167 131 188 112 - -
EPS (₹) 4.01 4.24 2.90 4.77 2.22 - -
Operating Margin (%) 27.0% 27.0% 24.0% 32.0% 26.0% - -

Sai Life Sciences Share Price Trend Around Quarterly Results

Visualize Sai Life Sciences's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Sai Life Sciences

Additional stock information and data for SAILIFE

Sai Life Sciences stock price NSE
SAILIFE price earnings ratio
SAILIFE yearly price range

Profitability Ratios

Profit Margin 15.2%
EBITDA Margin 29.1%
Operating Margin 27.0%
ROE (Annual) 15.8%

Balance Sheet Highlights

Total Assets ₹3,160 Cr
Total Equity ₹2,128 Cr
Current Assets ₹1,505 Cr
Current Liabilities ₹299 Cr

Cash Flow Analysis

Operating Cash Flow ₹314 Cr
Investing Cash Flow ₹-536 Cr
Financing Cash Flow ₹301 Cr
Net Cash Flow ₹79 Cr

Current Market Data

Current Price ₹959.95
Exchange NSE
Last Updated Apr 02, 2026

Revenue Trend (₹ Cr)

Dec 2025 565
Jun 2025 506
Mar 2025 589
Sept 2025 553

Net Profit Trend (₹ Cr)

Dec 2025 100
Jun 2025 61
Mar 2025 88
Sept 2025 84

Operating Margin Trend (%)

Dec 2025 32.0%
Jun 2025 24.0%
Mar 2025 27.0%
Sept 2025 27.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Sai Life Sciences quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1693.6 14,875 3,125 +10.8% - 21.0% 130.3
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5856.5 2,860 689 +7.1% - 24.1% 225.5
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 3987.2 3,219 591 +11.3% - 18.4% 227.3
Lupin
Sept 2025 		₹107,238.09 Cr 2274.5 6,921 1,485 +23.2% - 21.5% 70.3
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1217.3 9,135 1,337 +1.1% - 14.6% 75.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores